NCDC_DM Diabetes mellitus

Total number of individuals screened for

NCDC_DM_Sc1
Diabetes in the reporting Period
NCDC_DM_Sc1.1 40-49 :Male
NCDC_DM_Sc1.2 : Female
NCDC_DM_Sc1.3 50-59 :Male
NCDC_DM_Sc1.4 : Female
NCDC_DM_Sc1.5 60-69 :Male
NCDC_DM_Sc1.6 : Female
NCDC_DM_Sc1.7 >=70 :Male
NCDC_DM_Sc1.8 : Female
Total number of individuals with raised blood
NCDC_DM2 sugar  among screened in the reporting
period
NCDC_DM.2.1 40-49 :Male
NCDC_DM.2.2 : Female
NCDC_DM.2.3 50-59 :Male
NCDC_DM.2.4 : Female
NCDC_DM.2.5 60-69 :Male
NCDC_DM.2.6 : Female
NCDC_DM.2.7 >=70 :Male
NCDC_DM.2.8 : Female
Total number of new diabetic patients
NCDC_DM_NW3
enrolled to care in the reporting period
NCDC_DM_NW3.1 <40 :Male
NCDC_DM_NW3.2 : Female
NCDC_DM_NW3.3 40-49 :Male
NCDC_DM_NW3.4 : Female
NCDC_DM_NW3.5 50-59 :Male
NCDC_DM_NW3.6 : Female
NCDC_DM_NW3.7 60-69 :Male
NCDC_DM_NW3.8 : Female
NCDC_DM_NW3.7 >=70 :Male
NCDC_DM_NW3.8 : Female
Total Number of New diabetic Patients Put on
NCDC_DM_N_Rx3
drug treatment in the reporting period
Total Number of Diabetic Patients
NCDC_DM_TP4
disaggregated by type
NCDC_DM_TP4.1 Diabetes mellitus Type I
NCDC_DM_TP4.2 Diabetes mellitus Type II
NCDC_DM_TP4.3 Gestational Diabetes mellitus (GDM)
Total number of diabetic patients enrolled to care
NCDC_DM_Rx6
six month prior to the reporting month
NCDC_DM_Rx5.1 Controlled
NCDC_DM_Rx5.2 Not Controlled
NCDC_DM_Rx5.3 Lost to follow up
NCDC_DM_Rx5.4 Died
NCDC_DM_Rx5.5 Transfer out
NCDC_HT Hypertension
Total number of individuals screened for
NCDC_HT_Sc1
hypertension in the reporting Period
NCDC_HT_Sc1.3 30-49 :Male
NCDC_HT_Sc1.4 : Female
NCDC_HT_Sc1.5 50-69 :Male
NCDC_HT_Sc1.6 : Female
NCDC_HT_Sc1.7 >=70 :Male
NCDC_HT_Sc1.8 : Female

Total number of individuals with raised blood

NCDC_HT2
pressure among screened in the reporting period

NCDC_HT2.3 30-49 :Male

NCDC_HT2.4 : Female
NCDC_HT2.5 50-69 :Male
NCDC_HT2.6 : Female
NCDC_HT2.7 >=70 :Male
NCDC_HT2.8 : Female
Total number of new hypertensive patients
NCDC_HT_Nw3
enrolled to care
NCDC_HT_Nw3.1 <30 :Male
NCDC_HT_Nw3.2 : Female
NCDC_HT_Nw3.3 30-49 :Male
NCDC_HT_Nw3.4 : Female
NCDC_HT_Nw3.5 50-69 :Male
NCDC_HT_Nw3.6 : Female
NCDC_HT_Nw3.7 >=70 :Male
NCDC_HT_Nw3.8 : Female
Total Number of hypertensive Patients Put on
NCDC_HT_Nw_Rx3
drug treatment in the reporting period
Total Number of hypertensive patients
NCDC_HT_Nw4
enrolled to care disaggregated by Stage
NCDC_HT_Nw4.1 Stage I
NCDC_HT_Nw4.2 Stage II
Severe HTN ( Includng HTN emergency and
NCDC_HT_Nw4.3
Urgency
NCDC_HT_Nw4.4 others
Total number of New hypertensive patients put on
NCDC_HT_Nw_Rx3.
drug treatment in the reporting period

Total number of hypertensive patients enrolled to

NCDC_HT_Nw4
care six month prior to the reporting month
NCDC_HT_Rx5.1 Controlled
NCDC_HT_Rx5.2 Not Controlled
NCDC_HT_Rx5.3 Lost follow up
NCDC_HT_Rx5.4 Died
NCDC_HT_Rx5.5 Transfer out
NCDC_CVD Cardio vascular disease
NCDC_CVD1 Total Number of patients assesed for CVD risk

NCDC_CVD1.1 CVD risk < 10%( Low)

NCDC_CVD1.2 CVD risk 10%-20%(Moderate)
NCDC_CVD1.3 CVD risk 20%-30%(High)
NCDC_CVD1.4 CVD risk >=30%(Very High)

Number of patients with CVD risk ≥ 30% received

CVD_RX.1
treatment during the reporting period
sum

sum

sum

sum

sum
sum

sum

sum

sum

sum
sum